Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zarate

Showing results (51-60 of 707) with videos related to

Pageof 71
Sort By:
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1997
Combined valproate or carbamazepine and electroconvulsive therapyC A Zarate, M Tohen, G Baraibar
Psychiatry and Clinical Neurosciences|June 26, 2024
Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic interventionHiroe Hu, Carlos A Zarate, Joseph Verbalis
Waste Management (New York, N.Y.)|January 2, 2008
Capacity building in rural Guatemala by implementing a solid waste management programM A Zarate, J Slotnick, M Ramos
Molecular Psychiatry|April 4, 2024
Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?Brandi Quintanilla, Carlos A Zarate, Anilkumar Pillai
European Journal of Medical Genetics|September 24, 2013
Description of another case of 3q26.33-3q27.2 microdeletion supports a recognizable phenotypeYuri A Zarate, Carla Bell, Brad Schaefer
The American Journal of Psychiatry|September 5, 2001
Cycling into depression from a first episode of mania: a case-comparison studyC A Zarate, M Tohen, K Fletcher
Harvard Review of Psychiatry|September 1, 1996
The danger of hopefulness: a clozapine "cure" of chronic psychosisS Schwartzberg, J Wheelis, C A Zarate
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Underrepresented Minorities in Science: ACNP Strives to Increase Minority Representation and InclusionCarlos A Bolaños-Guzmán, Carlos A Zarate
Current Behavioral Neuroscience Reports|January 30, 2016
Novel Glutamatergic Treatments for Severe Mood DisordersMinkyung Park, Mark J Niciu, Carlos A Zarate
Expert Opinion on Drug Safety|March 1, 2022
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysisAnees Bahji, Carlos A Zarate, Gustavo H Vazquez
Pageof 71

Showing results (51-60 of 707) with videos related to

Sort By:
Pageof 71
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1997
Combined valproate or carbamazepine and electroconvulsive therapyC A Zarate, M Tohen, G Baraibar
Psychiatry and Clinical Neurosciences|June 26, 2024
Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic interventionHiroe Hu, Carlos A Zarate, Joseph Verbalis
Waste Management (New York, N.Y.)|January 2, 2008
Capacity building in rural Guatemala by implementing a solid waste management programM A Zarate, J Slotnick, M Ramos
Molecular Psychiatry|April 4, 2024
Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?Brandi Quintanilla, Carlos A Zarate, Anilkumar Pillai
European Journal of Medical Genetics|September 24, 2013
Description of another case of 3q26.33-3q27.2 microdeletion supports a recognizable phenotypeYuri A Zarate, Carla Bell, Brad Schaefer
The American Journal of Psychiatry|September 5, 2001
Cycling into depression from a first episode of mania: a case-comparison studyC A Zarate, M Tohen, K Fletcher
Harvard Review of Psychiatry|September 1, 1996
The danger of hopefulness: a clozapine "cure" of chronic psychosisS Schwartzberg, J Wheelis, C A Zarate
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Underrepresented Minorities in Science: ACNP Strives to Increase Minority Representation and InclusionCarlos A Bolaños-Guzmán, Carlos A Zarate
Current Behavioral Neuroscience Reports|January 30, 2016
Novel Glutamatergic Treatments for Severe Mood DisordersMinkyung Park, Mark J Niciu, Carlos A Zarate
Expert Opinion on Drug Safety|March 1, 2022
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysisAnees Bahji, Carlos A Zarate, Gustavo H Vazquez
Pageof 71